Why TD Cowen Calls The Cigna Group (CI) “A Best Ideas Pick” For 2026

Group 1 - The Cigna Group (NYSE:CI) is considered a cheap healthcare stock with a potential upside of 25.5%, as TD Cowen reaffirmed a 'Buy' rating and set a price target of $333 [1][2] - The company's earnings per share (EPS) for 2026 is projected to be within a specific range, and the stock is trading at a decade-low valuation, indicating it is "largely de-risked" [2] - Cigna's new rebate-free pharmacy benefit management (PBM) model is seen as a significant step towards broader PBM reforms, which could enhance valuation and address regulatory issues [2] Group 2 - Guggenheim also maintains a 'Buy' rating on The Cigna Group, raising its price target to $318 from $309, reflecting a 20% upside potential [4] - Cigna operates primarily through its Evernorth Health Services and Cigna Healthcare segments, providing insurance and related products and services [4]